Skip to content

Clinical trials

Phase 3 Musculoskeletal Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 3 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20152
20162
20173
20211
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
PTC Therapeutics2
Amgen1
Avidity Biosciences, Inc.1
BioMarin Pharmaceutical1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Fulcrum Therapeutics1
Kyntra Bio1
QED Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases16
Arthritis7
Joint Diseases7
Genetic Diseases, Inborn6
Arthritis, Rheumatoid5
Muscular Diseases5
Muscular Dystrophies5
Neuromuscular Diseases5
Muscular Disorders, Atrophic4
Muscular Dystrophy, Duchenne4

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.